Formaldehyde produced endogenously via deamination of methylamine. A potential risk factor for initiation of endothelial injury

Atherosclerosis

Volumn 120, Issue 1-2, 1996, Pages 189-197

  Yu, P H ^a   Zuo, D M ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Amine oxidase; Atherosclerosis; Cytotoxicity; Diabetes; Endothelial injury; Formaldehyde; Methylamine

Indexed keywords

FORMALDEHYDE; HYDROGEN PEROXIDE; METHYLAMINE; MOFEGILINE; PRORENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CIGARETTE SMOKING; CYTOTOXICITY; DEAMINATION; ENDOTHELIUM LESION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; STREPTOZOCIN DIABETES;

EID: 0030049845     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(95)05701-3     Document Type: Article

References (57)

1. Rau L. Hypertension, endothelium, and cardiovascular risk factors. Am J Med 1991;90(suppl 2A):13S-18S.
2. Lin SL, Hong CY, Chang MS, Chiang BN, Chien S. Long-term nicotine exposure increases aortic endothelial cell and enhances transendothelial macromolecular transport in rats. Atherioscler Thromb 1992;12:1305-1312.
3. Ross R. The pathogenesis of atherosclerosis - An update. N Engl J Med 1986;314:488-500.
4. Ross R, Glomset JA. The pathogenesis of atherosclerosis. N Engl J Med 1976;295:369-377.
5. Krauss RM. Tangled web of coronary risk factors. Am J Med 1991;90:2A36S-2A41S.
6. Scanu AM, Fless GM. Lipoprotein (a). Heterogeneity and biological relavance. J Clin Invest 1990;85:1709-1715.
7. Ward PA. Mechanisms of endothelial cell injury. J Lab Clin Med 1991;118:421-426.
8. Bierman EL. Atherogenesis in diabetes. Arterioscler Thromb 1992;12:647-656.
9. Precious E, Gunn CE, Lyles GA. Deamination of methylamine by semicarbazide-sensitive amine oxidase in human umbilical artery and rat aorta. Biochem Pharmacol 1988;37:707.
10. Yu PH. Oxidative deamination of aliphatic amines by rat aorta semicarbazide-sensitive amine oxidase. J Pharm Pharmacol 1990;42:882.
11. Boor P, Trent MB, Lyles GA, Tao M, Ansari GAS. Methylamine metabolism to formaldehyde by vascular semicarbazide-sensitive amine oxidase. Toxicology 1992;73:251-258.
12. Wibo M, Duong AT, Godfraind T. Subcellular location of semicarbazide-sensitive amine oxidase in rat aorta. Eur J Biochem 1980;112:87-94.
13. Lewinsohn R. Amine oxidase in human blood vessels and non-vascular smooth muscle. J Pharm Pharmacol 1981;33:569-575.
14. Lyles GA, Singh I. Vascular smooth muscle cells: A major source of the semicarbazide-sensitive amine oxidase of the rat aorta. J Pharm Pharmacol 1985;37:637-643.
15. Zuo DM, Yu PH. Semicarbazide-sensitive amine oxidase and monoamine oxidase in rat brain microvessels, meninges, retina and eye sclera. Brain Res Bull 1993;33:307-311.
16. Lyles GA, Holt A, Marshal CMS. Further studies on the metabolism of methylamine by semicarbazide-sensitive amine oxidase activities in human plasma. J Pharm Pharmacol 1990;42:322-338.
17. Yu PH, Zuo DM. Methylamine, a potential endogenous toxin for vascular tissues: Formation of formaldehyde via enzymatic deamination and the cytotoxic effects on endothelial cells. Diabetes 1993;42:594-603.
18. Blau K. Chromatographic methods for the study of amines from biological material. Biochem J 1961;80:193-200.
19. Baba S, Watanabe Y, Gejyo F, Arakwa M. High-performance liquid chromatographic determination of serum aliphatic amines in chronic renal failure. Clin Chim Acta 1984;136:49-56.
20. Asatoor AM, Kerr DNS. Amines in blood and urine in relation to liver disease. Clin Chim Acta 1961;6: 149-156.
21. Lyles GA, McDougall SA. The enhanced daily excretion of urinary methylamine in rats treated with semicarbazide or hydralazine may be related to the inhibition of semicarbazide-sensitive amine oxidase activities. J Pharm Pharmacol 1989;41:97-100.
22. Nixon R. Volatile amines in mouse brain: A radioassay with picogram sensitivity. Anal Biochem 1972;48:460-470.
23. Smith AD, Jepson JB. Chromatography of urinary and tissue amines and amino alcohols as 2,4-dinitrophenyl derivatives prepared with 2-nitrobenzenesulfonic acid. Anal Biochem 1967;18:36-45.
24. Schayer RW, Smiley LR, Kaplan HE. The metabolism of epinephrine containing isotopic carbon. J Biol Chem 1952;198:545-551.
25. Dar MS, Morselli PL, Bowman ER. The enzymatic systems involved in the mammalian metabolism of methylamine. Gen Pharmacol 1985;16:557-560.
26. Zeisel SH, Dacosta KA. Increase in human exposure to methylamine precursors of N-nitrosamines after eating fish. Cancer Res 1986;46:6136-6138.
27. US Dept Health and Human Services Constituents of tobacco smoke. USPHS Publication No. 82-50179, 1982;322.
28. Bolt HM. Experimental toxicology of formaldehyde. J Can Res Clin Oncol 1987;13:305-309.
29. Grafstrom RC, Curren RD, Yang LL, Harris CC. Genotoxicity of formaldehyde in cultured human bronchial fibroblasts. Science 1985;228:89-91.
30. Trézl L, Török G, Vasvári G, Pipek J. Formation of burst chemiluminescence, excited aldehydes, and singlet oxygen in model reactions and from carcinogenic compound in rat liver S9 fractions. In: Tyihak E (ed). Role of Formaldehyde in Biological Systems, Hungarian Biochem Soc, Sopron Hungary, 1992.
31. Sealey JE. Plasma renin activity and plasma prorenin assays. Clin Chem 1991;37:1811-1819.
32. Johannessen A, Nielsen AH, Poulsen K. Measurement of inactive renin in rat plasma: Effect of nephrectomy and sialoadenectomy on the plasma concentration. J Hypertens 1990;8:345-349.
33. Boor PJ, Hysmith RM. Allylamine cardiovascular toxicity. Toxicology 1987;44:129-144.
34. Boor PJ, Nelson TJ. Allylamine cardiotoxicity: III. Protection by semicarbazide and in vivo derangements of monoamine oxidase. Toxicology 1980;18:87-102.
35. Boor PJ, Sanduja R, Nelson TJ, Ansari GAS. In vivo metabolism of the cardiovascular toxin, allylamine. Biochem Pharmacol 1987;36:4347-4353.
36. Jones JD, Burnett PC. Implications of creatinine and gut flora in the uremic syndrome: Induction of 'creatinase' in colon contents of the rat by dietary creatinine. Clin Chem 1972;8:280-284.
37. Zeisel SH, Wishnok JS, Blusztjan JK. Formation of methylamines from ingested choline and lecithin. J Pharmacol Exp Therap 1983;225:320-324.
38. Malorny GN, Rietbrock N, Schneider M. The oxidation of formaldehyde to formic acid in the blood. A contribution to the metabolism of formaldehyde. Schmiedebergs Arch Exp Path Pharmak 1965;250:419-436.
39. Helander A, Tottmar O. Metabolism of biogenic aldehydes in isolated human blood cells, platelets and in plasma. Biochem Pharmacol 1987;36:1077-1082.
40. McEwen CM Jr, Castell DO. Abnormalities of serum monoamine oxidase in chronic liver disease. J Lab Clin Med 1967;70:36-47.
41. Nilsson SE, Tryding N, Tufvesson G. Serum monoamine oxidase in diabetes mellitus and some other internal diseases. Acta Med Scand 1968;184:105-108.
42. Tryding N, Nilsson SE, Tufvesson G, Berg R, Carlstrom S, Elmfors B, Nilsson JE. Physiological and pathological influences on serum monoamine oxidase level. Scan J Clin Lab Invest 1969;23:79-84.
43. Hayes BE, Clarke DE. Semicarbazide-sensitive amine oxidase activity in streptozotocin diabetic rats. Res Comm Chem Pathol Pharmacol 1990;69:71-83.
44. Elliott J, Fowden AL, Callingham BA, Sharman DF, Silver M. Physiological and pathological influences on sheep blood plasma amine oxidase: Effect of pregnancy and experimental alloxian-induced diabetes mellitus. Res Vet Sci 1991;50:334-339.
45. Lin SL, Hong CY, Chang MS, Chiang BN, Chien S. Increased aortic endothelial cell death and enhanced transendothelial macromolecular transport in streptozotocin-diabtetic rats. Diabetologia 1993;36:926-930.
46. Halimi J-M, Sealey JE. Prorenin in diabetes mellitus. Trends Endocrinol Metab 1992;3:270-275.
47. Frankenhaeuser M. Behavior and circulating catecholamines. Brain Res 1971;31:241-262.
48. Luetscher JA, Kraemer FB, Wilson DM. Prorenin and vascular complications of diabetes. Am J Hypertens 1989;2:382-386.
49. Kapeller-Adler R, Toda K. Über das Vorkommen von Monomethylamine im Harn. Biochem Zeischrift 1932;248:403-425.
50. von Euler US. Adrenal medullary secretion and its neural control. In: Martini L. Ganong WF, (eds). Neuroendocrinology vol. 2, New York: Academic Press, 1976;283-333.
51. Franken AAM, Derkx FMH, Blankestjn PJ, Janssen JAMJL, Mannesse CK, Hop W, Boomsma F, Weber R, Peperkamp E, De Jong PTVM, Schalekamp MADH. Plasma pro renin as an early marker of microvascular disease in patients with diabetes mellitus. Diabetes Metab 1992;18:137-143.
52. Wilens SL, Plair CM. Cigarette smoking and atherosclerosis. Science 1962;138:975-977.
53. Sackett DL, Winkelstein W. The relationship between cigarette usage and aortic atherosclerosis. Am J Epidemiol 1967;86:264-270.
54. Auerbach O, Hammond EC, Garfinkel L. Smoking in relation to atherosclerosis of the coronary arteries. N Engl J Med 1965;273:775-779.
55. Davis JW, Shelton L, Watanabe IS, Arnold J. Passive smoking affects endothelium and platelets. Arch Intern Med 1989;149:386-389.
56. Strong JP, Richards ML. Cigarette smoking and atherosclerosis in autopsied men. Atherosclerosis 1976;23:451-476.
57. McKennis Jr H, Turnbull LB, Schwartz SL, Tamake E, Bowman ER. Demethylation in the metabolism of (-)-nicotine. J Biol Chem 1962;237:541-546.